睡眠障碍导致帕金森病或相反的情况是真的:好的GABA晚安
Hayder M Al-Kuraishy1, Ali I Al-Gareeb1, Ali K Albuhadily1
1Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq.
CNS neuroscience & therapeutics
|March 16, 2024
概括
帕金森病 (PD) 涉及GABA放松调节,影响睡眠和运动/非运动症状. 增强GABA可能会改善PD,但需要更多的研究来理解这种双向关系.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是由于多巴胺基神经元损失导致的运动和非运动症状.
- 在PD中,GABA (氨酸) 通过保护 substantia nigra pars compacta.中的神经元,起到神经保护作用.
- GABAergic神经元的退化与多巴aminergic神经元损失和PD症状的进展有关.
研究的目的:
- 为了澄清GABA在PD神经病理学中的机械作用,特别是关于睡眠障碍.
- 探索如何改善GABA功能可能使PD患者受益.
- 调查睡眠障碍,如失眠和REM睡眠行为障碍 (RBD) 对PD神经病理和严重性的影响.
主要方法:
- 这是对已发表文章的叙述性回顾.
- 对PD中GABAergic神经递质的临床前和观察性研究的分析.
- 检查睡眠障碍与PD病变发生之间的关系.
主要成果:
- 在PD中睡眠障碍与改变的GABA神经传递有关,可能导致认知功能障碍.
- 失眠和睡眠时间缩短与大脑GABA水平降低相关.
- 与PD相关的症状,如刚性和夜,导致睡眠碎片化,可能会恶化PD神经病理.
结论:
- 在PD病原和睡眠障碍之间存在双向关系,可能由GABA放松调节介导.
- 建议对GABA激动剂进行进一步的前性研究,以管理PD的运动和非运动症状.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
相关概念视频
01:15REM Sleep Behavior Disorder
183
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
183
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
01:07Narcolepsy
102
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
102
01:24Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
01:14CNS Depressants: Barbiturates and Benzodiazepines
262
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
262